HIV vaccine design and the neutralizing antibody problem

被引:635
作者
Burton, DR
Desrosiers, RC
Doms, RW
Koff, WC
Kwong, PD
Moore, JP
Nabel, GJ
Sodroski, J
Wilson, IA
Wyatt, RT
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Div Microbiol, Southborough, MA 01772 USA
[4] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[5] Int AIDS Vaccine Initiat, New York, NY USA
[6] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA
[7] Cornell Univ, Weill Med Ctr, Dept Microbiol & Immunol, New York, NY USA
[8] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[9] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1038/ni0304-233
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 21 条
[1]
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition [J].
Calarese, DA ;
Scanlan, CN ;
Zwick, MB ;
Deechongkit, S ;
Mimura, Y ;
Kunert, R ;
Zhu, P ;
Wormald, MR ;
Stanfield, RL ;
Roux, KH ;
Kelly, JW ;
Rudd, PM ;
Dwek, RA ;
Katinger, H ;
Burton, DR ;
Wilson, IA .
SCIENCE, 2003, 300 (5628) :2065-2071
[2]
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120 [J].
Choe, H ;
Li, WH ;
Wright, PL ;
Vasilieva, N ;
Venturi, M ;
Huang, CC ;
Grundner, C ;
Dorfman, T ;
Zwick, MB ;
Wang, LP ;
Rosenberg, ES ;
Kwong, PD ;
Burton, DR ;
Robinson, JE ;
Sodroski, JG ;
Farzan, M .
CELL, 2003, 114 (02) :161-170
[3]
Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques [J].
Fouts, T ;
Godfrey, K ;
Bobb, K ;
Montefiori, D ;
Hanson, CV ;
Kalyanaraman, VS ;
DeVico, A ;
Pal, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11842-11847
[4]
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates [J].
Golding, H ;
Zaitseva, M ;
de Rosny, E ;
King, LR ;
Manischewitz, J ;
Sidorov, I ;
Gorny, MK ;
Zolla-Pazner, S ;
Dimitrov, DS ;
Weiss, CD .
JOURNAL OF VIROLOGY, 2002, 76 (13) :6780-6790
[5]
Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins [J].
Grundner, C ;
Mirzabekov, T ;
Sodroski, J ;
Wyatt, R .
JOURNAL OF VIROLOGY, 2002, 76 (07) :3511-3521
[6]
Viral persistence: HIV's strategies of immune system evasion [J].
Johnson, WE ;
Desrosiers, RC .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :499-518
[7]
The need for a global HIV vaccine enterprise [J].
Klausner, RD ;
Fauci, AS ;
Corey, L ;
Nabel, GJ ;
Gayle, H ;
Berkley, S ;
Haynes, BF ;
Baltimore, D ;
Collins, C ;
Douglas, RG ;
Esparza, J ;
Francis, DP ;
Ganguly, NK ;
Gerberding, JL ;
Johnston, MI ;
Kazatchkine, MD ;
McMichael, AJ ;
Makgoba, MW ;
Pantaleo, G ;
Piot, P ;
Shao, YM ;
Tramont, E ;
Varmus, H ;
Wasserheit, JN .
SCIENCE, 2003, 300 (5628) :2036-2039
[8]
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus [J].
Kwong, PD ;
Wyatt, R ;
Sattentau, QJ ;
Sodroski, J ;
Hendrickson, WA .
JOURNAL OF VIROLOGY, 2000, 74 (04) :1961-1972
[9]
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1 [J].
Labrijn, AF ;
Poignard, P ;
Raja, A ;
Zwick, MB ;
Delgado, K ;
Franti, M ;
Binley, J ;
Vivona, V ;
Grundner, C ;
Huang, CC ;
Venturi, M ;
Petropoulos, CJ ;
Wrin, T ;
Dimitrov, DS ;
Robinson, J ;
Kwong, PD ;
Wyatt, RT ;
Sodroski, J ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (19) :10557-10565
[10]
Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design [J].
Pantophlet, R ;
Wilson, IA ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5889-5901